Question
Problem 5-27 (Algo) (LO 5-2, 5-3, 5-4, 5-5) On January 1, 2023, Pulaski, Incorporated, acquired a 60 percent interest in the common stock of Sheridan,
Problem 5-27 (Algo) (LO 5-2, 5-3, 5-4, 5-5)
On January 1, 2023, Pulaski, Incorporated, acquired a 60 percent interest in the common stock of Sheridan, Incorporated, for $384,600. Sheridan's book value on that date consisted of common stock of $100,000 and retained earnings of $227,300. Also, the acquisition-date fair value of the 40 percent noncontrolling interest was $256,400. The subsidiary held patents (with a 10-year remaining life) that were undervalued within the company's accounting records by $78,400 and also had unpatented technology (15-year estimated remaining life) undervalued by $54,300. Any remaining excess acquisition-date fair value was assigned to an indefinite-lived trade name. Since acquisition, Pulaski has applied the equity method to its Investment in Sheridan account. At year-end, there are no intra-entity payables or receivables.
Intra-entity inventory sales between the two companies have been made as follows:
Year | Cost to Pulaski | Transfer Price to Sheridan | Ending Balance (at transfer price) |
---|---|---|---|
2023 | $ 127,200 | $ 159,000 | $ 53,000 |
2024 | 112,500 | 150,000 | 37,500 |
The individual financial statements for these two companies as of December 31, 2024, and the year then ended follow:
Items | Pulaski, Incorporated | Sheridan, Incorporated |
---|---|---|
Sales | $ (732,000) | $ (367,000) |
Cost of goods sold | 481,100 | 224,200 |
Operating expenses | 197,185 | 76,400 |
Equity in earnings in Sheridan | (34,189) | 0 |
Net income | $ (87,904) | $ (66,400) |
Retained earnings, 1/1/24 | $ (774,600) | $ (282,800) |
Net income | (87,904) | (66,400) |
Dividends declared | 47,900 | 18,600 |
Retained earnings, 12/31/24 | $ (814,604) | $ (330,600) |
Cash and receivables | $ 277,400 | $ 150,500 |
Inventory | 260,500 | 131,200 |
Investment in Sheridan | 423,453 | 0 |
Buildings (net) | 338,000 | 205,300 |
Equipment (net) | 241,300 | 89,100 |
Patents (net) | 0 | 23,600 |
Total assets | $ 1,540,653 | $ 599,700 |
Liabilities | $ (426,049) | $ (169,100) |
Common stock | (300,000) | (100,000) |
Retained earnings, 12/31/24 | (814,604) | (330,600) |
Total liabilities and equities | $ (1,540,653) | $ (599,700) |
Note: Parentheses indicate a credit balance.
Required:
Show how Pulaski determined the $423,453 Investment in Sheridan account balance. Assume that Pulaski defers 100 percent of downstream intra-entity profits against its share of Sheridans income.
Prepare a consolidated worksheet to determine appropriate balances for external financial reporting as of December 31, 2024.
Required:
Show how Pulaski determined the $423,453 Investment in Sheridan account balance. Assume that Pulaski defers 100 percent of downstream intra-entity profits against its share of Sheridans income.
Prepare a consolidated worksheet to determine appropriate balances for external financial reporting as of December 31, 2024.
Required:
Show how Pulaski determined the $423,453 Investment in Sheridan account balance. Assume that Pulaski defers 100 percent of downstream intra-entity profits against its share of Sheridans income.
Prepare a consolidated worksheet to determine appropriate balances for external financial reporting as of December 31, 2024.
Step by Step Solution
There are 3 Steps involved in it
Step: 1
Get Instant Access to Expert-Tailored Solutions
See step-by-step solutions with expert insights and AI powered tools for academic success
Step: 2
Step: 3
Ace Your Homework with AI
Get the answers you need in no time with our AI-driven, step-by-step assistance
Get Started